Literature DB >> 19603780

2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.

Jiyun Shi1, Young-Seung Kim, Sudipta Chakraborty, Bing Jia, Fan Wang, Shuang Liu.   

Abstract

This report describes the synthesis of MAG(2)-PEG(4)-E[c(RGDfK)](2) (MAG(2)-P-RGD(2): MAG(2) = S-benzoylmercaptoacetylglycylglycyl; PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid) and MAG(2)-PEG(4)-E[PEG(4)-c(RGDfK)](2) (MAG(2)-3P-RGD(2)), and the evaluation of (99m)TcO(MAG(2)-P-RGD(2)) and (99m)TcO(MAG(2)-3P-RGD(2)) as new radiotracers for tumor imaging in the athymic nude mice bearing U87MG human glioma xenografts. We found that MAG(2) is such an efficient bifunctional chelating agent that (99m)TcO(MAG(2)-P-RGD(2)) and (99m)TcO(MAG(2)-3P-RGD(2)) coul d be prepared in high yield (>90%) with high specific activity (∼5 Ci/μmol) using a kit formulation. (99m)TcO(MAG(2)-P-RGD(2)) and (99m)TcO(MAG(2)-3P-RGD(2)) have very high solution stability in the kit matrix. Biodistribution data in athymic nude mice bearing U87MG human glioma xenografts indicated that replacing the highly charged [(99m)Tc(HYNIC = 6-hydrazinonicotinyl and TPPTS = trisodium triphenylphosphine-3,3',3''-trisulfonate) with smaller (99m)TcO(MAG(2)) resulted in a significant increase in the radiotracer uptake in the tumor and normal organs most likely due to the higher lipophilicity of (99m)TcO(MAG(2)-3P-RGD(2)) (log P = -3.15 ± 0.10) than that for [(99m)Tc(HYNIC-3P-RGD(2))(tricine)(TPPTS)] ((99m)Tc-3P-RGD(2): log P = -3.96 ± 0.05). Even though (99m)TcO(MAG(2)-3P-RGD(2)) has better tumor uptake (15.36 ± 2.17 %ID/g at 60 min postinjection (p.i.)) than (99m)Tc-3P-RGD(2) (9.15 ± 2.13 %ID/g at 60 min p.i.), its tumor-to-background (T/B) ratios (tumor/blood = 13.52 ± 4.57; tumor/liver = 4.25 ± 0.88; tumor/lung = 3.17 ± 0.60; and tumor/muscle = 8.34 ± 2.34) are not as good as those of (99m)Tc-3P-RGD(2) (tumor/blood = 36.0 ± 11.5; tumor/liver = 5.14 ± 1.46; tumor/lung = 4.36 ± 0.54; and tumor/muscle = 13.70 ± 2.21) at 60 min p.i. On the basis of these results, we believe that (99m)Tc-3P-RGD(2) remains a better radiotracer because of its higher T/B ratios.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603780      PMCID: PMC2888811          DOI: 10.1021/bc9001739

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  56 in total

Review 1.  Advances in anatomic, functional, and molecular imaging of angiogenesis.

Authors:  Andrew R Hsu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2008-04       Impact factor: 10.057

2.  In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).

Authors:  Susana Alves; João D G Correia; Lurdes Gano; Tammy L Rold; Adam Prasanphanich; Roland Haubner; Marco Rupprich; Roger Alberto; Clemens Decristoforo; Isabel Santos; Charles J Smith
Journal:  Bioconjug Chem       Date:  2007 Mar-Apr       Impact factor: 4.774

3.  (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.

Authors:  Zi-Bo Li; Kai Chen; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-19       Impact factor: 9.236

4.  99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.

Authors:  Jianjun Wang; Young-Seung Kim; Shuang Liu
Journal:  Bioconjug Chem       Date:  2008-02-19       Impact factor: 4.774

5.  Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.

Authors:  Shuang Liu; Young-Seung Kim; Wen-Yuan Hsieh; Subramanya Gupta Sreerama
Journal:  Nucl Med Biol       Date:  2007-11-19       Impact factor: 2.408

6.  [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.

Authors:  Ambros J Beer; Anca-Ligia Grosu; Janette Carlsen; Andreas Kolk; Mario Sarbia; Isabelle Stangier; Petra Watzlowik; Hans-Jürgen Wester; Roland Haubner; Markus Schwaiger
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

7.  Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer.

Authors:  Bing Jia; Zhaofei Liu; Jiyun Shi; Zilin Yu; Zhi Yang; Huiyun Zhao; Zhengjie He; Shuang Liu; Fan Wang
Journal:  Bioconjug Chem       Date:  2007-12-11       Impact factor: 4.774

Review 8.  Multimodality molecular imaging of tumor angiogenesis.

Authors:  Weibo Cai; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

9.  Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients.

Authors:  Laura M Kenny; R Charles Coombes; Inger Oulie; Kaiyumars B Contractor; Matthew Miller; Terence J Spinks; Brian McParland; Pamela S Cohen; Ai-Min Hui; Carlo Palmieri; Safiye Osman; Matthias Glaser; David Turton; Adil Al-Nahhas; Eric O Aboagye
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

10.  Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.

Authors:  Roland Haubner; Wolfgang A Weber; Ambros J Beer; Eugenija Vabuliene; Daniel Reim; Mario Sarbia; Karl-Friedrich Becker; Michael Goebel; Rüdiger Hein; Hans-Jürgen Wester; Horst Kessler; Markus Schwaiger
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

View more
  19 in total

1.  Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.

Authors:  Yang Zhou; Young-Seung Kim; Xin Lu; Shuang Liu
Journal:  Bioconjug Chem       Date:  2012-03-06       Impact factor: 4.774

2.  Biodistribution and Internal Radiation Dosimetry of 99mTc-IDA-D-[c(RGDfK)]2 (BIK-505), a Novel SPECT Radiotracer for the Imaging of Integrin αvβ3 Expression.

Authors:  Yoo Sung Song; Joong Hyun Kim; Byung Chul Lee; Jae Ho Jung; Hyun Soo Park; Sang Eun Kim
Journal:  Cancer Biother Radiopharm       Date:  2018-08-22       Impact factor: 3.099

3.  Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent.

Authors:  Sudipta Chakraborty; Jiyun Shi; Young-Seung Kim; Yang Zhou; Bing Jia; Fan Wang; Shuang Liu
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

4.  Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging.

Authors:  Zuo-Quan Zhao; Yong Yang; Wei Fang; Shuang Liu
Journal:  Nucl Med Biol       Date:  2016-02-27       Impact factor: 2.408

5.  Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Authors:  Irene Tsiapa; George Loudos; Eirini A Fragogeorgi; Penelope Bouziotis; Dimitrios Psimadas; Stavros Xanthopoulos; Maria Paravatou-Petsotas; Lazaros Palamaris; Alexandra D Varvarigou; Dimitris Karnabatidis; George C Kagadis
Journal:  Cancer Biother Radiopharm       Date:  2014-12       Impact factor: 3.099

6.  (111)In- and (203)Pb-Labeled Cyclic RGD Peptide Conjugate as an α(v)β(3) Integrin-Binding Radiotracer.

Authors:  Kido Nwe; Young-Seung Kim; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  J Labelled Comp Radiopharm       Date:  2012-09-05       Impact factor: 1.921

7.  Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA).

Authors:  Sangeeta Ray Banerjee; Mrudula Pullambhatla; Catherine A Foss; Alexander Falk; Youngjoo Byun; Sridhar Nimmagadda; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2013-07-22       Impact factor: 7.446

Review 8.  Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2015-08-03       Impact factor: 4.774

9.  Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.

Authors:  Shundong Ji; Yang Zhou; Guoqiang Shao; Shuang Liu
Journal:  Bioconjug Chem       Date:  2013-04-08       Impact factor: 4.774

10.  (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.

Authors:  Shundong Ji; Andrzej Czerwinski; Yang Zhou; Guoqiang Shao; Francisco Valenzuela; Paweł Sowiński; Satendra Chauhan; Michael Pennington; Shuang Liu
Journal:  Mol Pharm       Date:  2013-08-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.